Osphena, Senshio (ospemifene) is a small molecule pharmaceutical. Ospemifene was first approved as Osphena on 2013-02-26. It is used to treat atrophy, dyspareunia, and menopause in the USA. It has been approved in Europe to treat postmenopause. Osphena's patents are valid until 2028-07-09 (FDA).
|Indication||atrophy, dyspareunia, menopause, postmenopause|
|Drug Class||Antiestrogens of the clomifene and tamoxifen groups|